Post job

ERYTECH Pharma's revenue is $8.5 million.

What is ERYTECH Pharma's revenue?

ERYTECH Pharma's annual revenue is $8.5M. Zippia's data science team found the following key financial metrics about ERYTECH Pharma after extensive research and analysis.
  • ERYTECH Pharma has 200 employees, and the revenue per employee ratio is $42,735.
  • ERYTECH Pharma peak revenue was $8.5M in 2024.

On this page

Peak revenue
$8.5M (2024)
Company peak revenue
Revenue / employee
$42,735
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$8.5M (2024)
Company peak revenue
Revenue / employee
$42,735
Company revenue / employee

ERYTECH Pharma financing

ERYTECH Pharma received early financing of $782.1K on 2005-11-03.

SeriesRound sizeDate
Series A$782K11/2005
Series Unknown$12.5M12/2006
Series B$5.2M07/2010
Series C$4.2M07/2011
Series D$15.6M04/2013
Post Ipo Equity$38.8M10/2014
Post Ipo Equity$26.5M12/2015
Private Equity$73.5M04/2017
Post Ipo Debt$10.4M11/2020

ERYTECH Pharma investors

InvestorsSecurity type
KARISTASeries A
Amorçage Rhône AlpesSeries A
Idinvest PartnersSeries Unknown
KARISTASeries Unknown
Amorçage Rhône AlpesSeries Unknown
ARDIANSeries Unknown
AURIGA PARTNERSSeries Unknown
AURIGA PARTNERSSeries B
AURIGA PARTNERSSeries C
AURIGA PARTNERSSeries D
BPIFRANCEPost Ipo Debt
Societe GeneralePost Ipo Debt

ERYTECH Pharma revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of ERYTECH Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about ERYTECH Pharma. The employee data is based on information from people who have self-reported their past or current employments at ERYTECH Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by ERYTECH Pharma. The data presented on this page does not represent the view of ERYTECH Pharma and its employees or that of Zippia.

ERYTECH Pharma may also be known as or be related to ERYTECH PHARMA, ERYTECH Pharma, ERYTECH Pharma S.A., ERYTECH Pharma SA, Erytech Pharma S.A. and Erytech Pharma SA.